| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 3817538 | PET Clinics | 2007 | 7 Pages |
Abstract
This article describes the use of 18F-fluorodeoxyglucose PET in patients who have head and neck cancer for assessment of therapy response, detection of locoregional recurrence and distant metastasis, and surveillance.
Related Topics
Health Sciences
Medicine and Dentistry
Medicine and Dentistry (General)
Authors
Rathan M. Subramaniam, Val J. Lowe,